Exhibition Announcement · November 2026
Come And Meet Us At CPHI India 2026
International Pharmaceutical Ingredients Exhibition · Delhi, India
Delhi, India – November 23–25, 2026 – Xiamen Origin Biotech is pleased to announce its participation in CPHI India 2026 (International Pharmaceutical Ingredients Exhibition) , one of South Asia's most significant pharmaceutical exhibitions, held at IICC, Delhi , with PMEC India co-located at IEML, Greater Noida. India is today one of the world's most dynamic pharmaceutical markets - a global hub for generic drug manufacturing, API production, and pharmaceutical exports - and CPHI India is where that industry's best minds and businesses come together.
Origin Biotech's presence at CPHI India 2026 is a deliberate step toward deepening our engagement with the Indian pharmaceutical sector. With a strong product portfolio spanning human pharmaceutical raw materials, APIs, finished dosage forms, and veterinary products, we are here to explore meaningful partnerships with India's world-class manufacturers, formulators, and distributors.
Exhibition
CPHI India 2026
International Pharmaceutical Ingredients Exhibition
Date
November 23–25, 2026
Location
Delhi, India
Venue
IICC, Delhi
PMEC India: IEML, Greater Noida
Our Booth
2A51
India - A Pharmaceutical Powerhouse
India's pharmaceutical industry is among the most respected in the world. As one of the largest producers of generic medicines globally and a major supplier of APIs to international markets, India plays a critical role in keeping the global pharmaceutical supply chain running. For Origin Biotech, engaging directly with this market is both a strategic priority and a natural fit.
The Indian pharmaceutical sector's commitment to quality, affordability, and innovation closely mirrors our own values - and we look forward to building connections with companies that share that mindset at CPHI India 2026.
What We Will Showcase at Booth 2A51
Pharmaceutical Raw Materials & APIs
Our core offering of high-purity pharmaceutical raw materials and APIs serves the full spectrum of human drug development and manufacturing. Each product is backed by rigorous quality testing and comprehensive documentation designed to support regulatory submissions in major markets worldwide.
▸ High-purity APIs for human pharmaceutical formulations
▸ Pharmaceutical excipients and bioactive compounds
▸ Full regulatory documentation and certificates of analysis
Finished Dosage Forms (FDF)
Origin Biotech's finished dosage form manufacturing capability makes us a comprehensive supply partner - offering Indian pharmaceutical companies the option to source both raw materials and finished products from one trusted manufacturer, simplifying procurement and strengthening quality oversight.
▸ Human and veterinary FDF manufactured under GMP standards
▸ A diverse range of dosage forms across multiple therapeutic categories
▸ Contract manufacturing for third-party brands and private label products
Veterinary Pharmaceutical Products
India's veterinary pharmaceutical market is growing rapidly alongside its livestock and animal agriculture sectors. Origin Biotech brings the same manufacturing rigor applied in human pharma production to our veterinary product range - offering Indian animal health companies a reliable international source for high-quality veterinary APIs and FDF.
▸ Veterinary APIs with complete technical and regulatory support
▸ Finished veterinary dosage forms for a wide range of indications
▸ Scalable supply from development to commercial volumes
Why Attend CPHI India 2026?
CPHI India is the premier platform for the South Asian pharmaceutical industry, connecting domestic manufacturers with international suppliers and opening doors to global market opportunities. It is an essential event for anyone involved in pharmaceutical raw materials, drug development, or the broader healthcare supply chain in the region.
▸ Connect with India's leading pharmaceutical manufacturers and generic drug producers
▸ Explore raw material and API sourcing opportunities from international suppliers
▸ Understand India's regulatory environment and market access requirements
▸ Discover contract manufacturing and technology transfer opportunities
▸ Build long-term business relationships across the South Asian pharmaceutical sector
Principal Advantages of Partnering With Origin Biotech
A versatile manufacturer covering both human and animal health pharmaceutical needs under one quality management system.
End-to-end manufacturing from raw material through to market-ready finished product - your supply chain, simplified.
Internationally compliant manufacturing facilities ensuring product quality, consistency, and regulatory readiness.
Complete technical dossiers and regulatory support to facilitate product approvals in India and international markets.
Flexible volumes from pilot batch to full commercial supply - we grow with your business needs.
We build lasting relationships based on reliability, transparency, and a shared commitment to quality outcomes.
Visit Us at Booth 2A51
November 23–25, 2026 · IICC, Delhi, India
Xiamen Origin Biotech warmly welcomes all colleagues, partners, and pharmaceutical professionals to visit Booth 2A51 at CPHI India 2026. We look forward to meaningful conversations and discovering what we can build together with India's exceptional pharmaceutical industry.
Concerning Origin Biotech
Xiamen Origin Biotech is a dedicated manufacturer of pharmaceutical raw materials and finished dosage forms for both human and veterinary applications. With a strong foundation in quality manufacturing, regulatory compliance, and scientific expertise, we serve clients across the pharmaceutical, nutraceutical, and animal health industries worldwide.
Are You Looking for a Reliable Pharmaceutical Supply Partner?
We are ready to offer:
We look forward to welcoming you at Booth 2A51, IICC Delhi - see you at CPHI India 2026!